Royal Bank of Canada’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-3,900
Closed -$83K 6807
2019
Q2
$83K Buy
3,900
+300
+8% +$6.29K ﹤0.01% 4980
2019
Q1
$86K Buy
3,600
+2,200
+157% +$50.2K ﹤0.01% 4863
2018
Q4
$28K Buy
+1,400
New +$25K ﹤0.01% 5410
2016
Q3
Sell
-100,000
Closed -$781K 6436
2016
Q2
$781K Hold
100,000
﹤0.01% 3315
2016
Q1
$400K Hold
100,000
﹤0.01% 3840
2015
Q4
$564K Buy
+100,000
New +$560K ﹤0.01% 3658
2014
Q3
Sell
-44,400
Closed -$151K 6009
2014
Q2
$151K Hold
44,400
﹤0.01% 4339
2014
Q1
$157K Buy
+44,400
New +$302K ﹤0.01% 4281

Other funds holding EXEL

Royal Bank of Canada's EXEL Position: Q1 2026 in Review

Royal Bank of Canada increased its Exelixis (EXEL) stake by 25% in Q1 2026, buying an estimated $5.89M and bringing the position to 694,131 shares worth $29.8M. The position accounts for 0.01% of the portfolio, ranked #1191.

Royal Bank of Canada first reported a position in EXEL in Q2 2013 and has held it in 52 quarters since. The position peaked at $82M in Q2 2025. 697 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Royal Bank of Canada held 694,131 shares of Exelixis worth $29.8M as of Q1 2026.
  • Royal Bank of Canada bought 136,976 Exelixis shares in Q1 2026, an estimated $5.89M.
  • Exelixis made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1191 holding.
  • Royal Bank of Canada first reported a position in Exelixis in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Exelixis position peaked at $82M in Q2 2025.
  • 697 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.